Additionally, a downstream phosphorylation target and likely physiological effector of mTOR signaling, the S6 ribosomal protein, shows increased phosphorylation (phospho-S6) in roughly 40 percent of colorectal carcinomas (CRCs) and adenomas [4]. The gene discussed is RPS6; the disease is adenoma.